Skip to content

Electroacupuncture Analgesia for Colonoscopy

Electroacupuncture Analgesia for Colonoscopy: a Prospective, Randomized, Double-blind, Sham-controlled Study

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01368393
Enrollment
128
Registered
2011-06-08
Start date
2011-10-31
Completion date
2012-10-31
Last updated
2012-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Brief summary

Background: Colonoscopy is often regarded as a painful and unpleasant procedure. Electroacupuncture (EA) has been used successfully to treat pain of various origins, but few good-quality studies have evaluated its role in treating pain and anxiety during colonoscopy. Objective: To investigate the efficacy of EA in reducing procedure-related pain and the consumption of sedatives/analgesics during colonoscopy. Design: Prospective, randomized, double-blind, sham-controlled study. Subjects: One hundred and twenty eight consecutive patients undergoing first-time elective day-case colonoscopy without previous experience of acupuncture will be recruited. Interventions: Patients will be randomized to receive either 45 minutes of EA or sham acupuncture (SA) before colonoscopy. The acupoints relevant to the treatment of abdominal pain, including Zusanli, Hegu, and Neiguan will be used. For the SA group, blunt-tip needles will be placed (without skin penetration) 15 mm away from the acupoints. Foam blocks will be used to stabilize the needles and to blind the patients and endoscopists to the treatment allocation. EA and SA will be continued throughout colonoscopy. A mixture of Propofol and Alfentanil, delivered by a patient-controlled syringe pump, will be used for sedation/analgesia in both groups. Outcome measures: Primary outcome: doses of patient-controlled sedation/analgesia consumed. Secondary outcomes: pain and satisfaction scores according to a visual analog scale, cecal intubation rate/time, and episodes of hypotension/desaturation.

Interventions

PROCEDUREElectroacupuncture

Patients randomized to the experimental group will receive electroacupuncture at acupoints relevant to the treatment of abdominal pain and anxiety, including Zusanli (stomach meridian ST-36), Hegu (large intestine meridian LI-4), and Neiguan (pericardium meridian PC-6). Electric stimulation will be employed to the needles

PROCEDURESham acupuncture

Sterile blunt-tip needles will be placed (without skin penetration) 15 mm away from the acupoints. Pseudostimulation will be given by deliberately connecting the needle to the incorrect output socket of the electroacupuncture device, thus there will be no flow of electric current.

Sponsors

Chinese University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Consecutive patients (aged between 18 and 60 years) undergoing first-time elective day-case colonoscopy * Patients with American Society of Anesthesiologists (ASA) grading I-II * Informed consent available

Exclusion criteria

* Patients with previous experience of acupuncture * Patients with previous history of colorectal surgery * Patients who are diagnosed with irritable bowel syndrome according to Rome III criteria * Patients with chronic pain syndrome * Patients with psychiatric disorder * Patients with poor cognitive function * Patients with renal impairment * Patients with obstructive sleep apnea syndrome * Patients with cardiac arrhythmias * Patients with cardiac pacemaker * Patients who are pregnant * Patients who are allergic to the acupuncture needles or Propofol/Alfentanil

Design outcomes

Primary

MeasureTime frame
Dose of patient-controlled sedation/analgesia consumedDuring the procedure (up to 1 day)

Secondary

MeasureTime frameDescription
Patients' satisfaction scoreDuring the procedure (up to 1 day)Using a 10-cm unscaled visual analog scale; 0 = not satisfied, 10 = very satisfied
Patients' willingness to repeat the procedureUp to 1 day
Endoscopists' satisfaction scoreDuring the procedure (up to 1 day)Using a 10-cm unscaled visual analog scale; 0 = not satisfied, 10 = very satisfied
Cecal intubation rateDuring the procedure (up to 1 day)Complete colonoscopy is defined as identification of ileocecal valve
Pain scoreDuring the procedure (up to 1 day)Using a 10-cm unscaled visual analog scale; 0 = no pain, 10 = very painful
Total procedure timeDuring the procedure (up to 1 day)
Episodes of hypotensionDuring the procedure (up to 1 day)Defined as systolic blood pressure \<90 mmHg
Episodes of desaturationDuring the procedure (up to 1 day)Defined as SaO2 \<90%
Cecal intubation timeDuring the procedure (up to 1 day)The time from introduction of the colonoscope to the cecum

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026